5360 Northwest 35th Avenue
Fort Lauderdale, FL 33309
Full Time Employees: 155
|Mr. Jyotindra R. Gange||Interim Principal Exec. Officer & Director||N/A||N/A||1949|
|Mr. John S. Copanos||VP of Bus. Devel. of Kirk Pharmaceuticals LLC||232.93k||N/A||1971|
|Mr. John R. Palmer||Chairman of InCon Technologies Inc.& Incon International Ltd. & CEO of InCon Technologies Inc||N/A||N/A||1943|
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Synovics Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.